Related Experiment Video
Updated: May 24, 2026

19:32
Preterm EEG: A Multimodal Neurophysiological Protocol
Published on: February 18, 2012
A standardized template for clinical studies in preterm birth
Leslie Myatt1, David A Eschenbach, Stephen J Lye
1Department of Obstetrics and Gynecology, University of Texas Health Science Center San Antonio, San Antonio, TX 78229-3900, USA. myattl@uthscsa.edu
Reproductive Sciences (Thousand Oaks, Calif.)
|February 21, 2012
Summary
This study introduces a standardized template to improve preterm birth research. Harmonized definitions and study designs will enable better data comparison and meta-analyses for this global health issue.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Clinical Research Methodology
Background:
- Preterm birth is a leading cause of neonatal morbidity and mortality globally.
- It's a complex condition with diverse clinical phenotypes and etiologies.
- Current research is hindered by inconsistent study designs, definitions, and data heterogeneity.
Purpose of the Study:
- To provide a harmonized, open-source template for designing clinical studies on preterm birth.
- To standardize definitions, patient phenotyping, and data collection for improved research comparability.
- To facilitate more robust meta-analyses and clinical translation of preterm birth data.
Main Methods:
- Recommendations for standardized clinical definitions and preterm birth phenotypes (infection, uterine overdistension, hemorrhage, stress, idiopathic).
- Guidelines for selecting study populations, control groups, and identifying confounding factors (e.g., maternal conditions, multifetal pregnancy).
- Provisions for study design, sample size calculations, and essential data set requirements.
Main Results:
- Identified five key preterm birth phenotypes: infection, uterine overdistension, hemorrhage, stress, and idiopathic.
- Outlined critical confounding factors: maternal medical conditions, obesity, antenatal glucocorticoids, multifetal pregnancies, and fetal sex.
- Provided universal guidelines for study design, sample size, and clinical data acquisition.
Conclusions:
- Adopting this harmonized template will enhance study protocol compatibility.
- It will enable direct comparison of data from different preterm birth studies.
- Facilitates pooling of samples and data sets for more meaningful and powerful meta-analyses.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

